SEC Form D · filed May 31, 2019
INNOVATE BIOPHARMACEUTICALS, INC
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (17)
Lorin K. Johnson · Raleigh, NCDirectorSandeep Laumas · Raleigh, NCExec · DirectorSaira K. Ramasastry · Raleigh, NCDirectorRoy K. Proujansky · Raleigh, NCDirectorJay P. Madan · Raleigh, NCExec · DirectorJeffrey Myers · New York, NYDirectorRuan Van Vuuren · Grand Cayman, Cayman IslandsDirectorJohn Bykowski · Hayward, CAExec · DirectorArnar Agnarsson · Bozeman, MTDirectorScott Zeilinger · New York, NYExec · DirectorAnthony E. Maida Iii · Raleigh, NCDirectorKevin Cavenaugh · Portland, ORExec · DirectorLorne Thomas · Odessa, FLExec · DirectorWilliam P. Corry · Sewickley, PADirectorChristopher Long · Mission Woods, KSDirectorCampbell Congdon · Grand Cayman, Cayman IslandsDirectorAnthony E. Maida Iii · Raleigh, NCDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗